Which of the following is an NSAID for Alzheimer’s disease, that lead to Phase III clinical trials?
A. Bapineuzumab
B. Alzhemed
C. Flurizan
D. Doxil
Answer:C
Which of the following is an NSAID for Alzheimer’s disease, that lead to Phase III clinical trials?
A. Bapineuzumab B. Alzhemed C. Flurizan D. Doxil